日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection

优化直肠癌新辅助治疗疗效评估,以降低ypT0N0切除率

Hew, Jonathan; Mohtashami, Ali; Mastrocostas, Katerina; Skinner, Tracey; De Silva, Keshani; Pavlakis, Nick; Hruby, George; Evans, Justin; Salama, Yasser; Kneebone, Andrew; Chang, Kah Hoong

The Surgeon's Hand: The Most Sensitive Instrument in Detection of Small Bowel Neuroendocrine Tumors

外科医生的手:检测小肠神经内分泌肿瘤最敏感的工具

Falon, Jessica; Kotecha, Krishna; Pavlakis, Nick; Gill, Anthony J; Mittal, Anubhav; Samra, Jaswinder S

Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experience

神经内分泌肿瘤肽受体放射性核素治疗后发生的治疗相关性髓系肿瘤:单中心病例系列报告的特征和结果

Chow, Wallace; Wen, Ivy; Mok, Claire; Huang, Kathryn; Stevenson, William; Roach, Paul J; Bailey, Dale L; Diakos, Connie I; Clarke, Stephen J; Pavlakis, Nick; Chan, David L

Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA)

澳大利亚ALK阳性晚期非小细胞肺癌的治疗模式、预后因素和生存情况:来自澳大利亚胸部癌症纵向队列研究和生物样本库(AURORA)的结果

Chazan, Grace; Alexander, Marliese; Franchini, Fanny; IJzerman, Maarten; Shah, Roma; John, Ani; Spelman, Tim; Itchins, Malinda; Pavlakis, Nick; Nagrial, Adnan; Warburton, Lydia; Bowyer, Samantha; Kao, Steven; Parakh, Sagun; Solomon, Benjamin J

First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial

在III期EXCLAIM-2试验中,一线Mobocertinib与铂类化疗在EGFR 20号外显子插入阳性转移性非小细胞肺癌患者中的疗效比较

Jänne, Pasi A; Wang, Bin-Chao; Cho, Byoung Chul; Zhao, Jun; Li, Juan; Hochmair, Maximilian; Peters, Solange; Besse, Benjamin; Pavlakis, Nick; Neal, Joel W; Kato, Terufumi; Wu, Yi-Long; Nguyen, Danny; Lin, Junjing; Lin, Jianchang; Vranceanu, Florin; Szumski, Annette; Lin, Huamao M; Fram, Robert J; Mok, Tony S K

A signal-seeking phase 2 study of tremelimumab in advanced cancers with high tumour mutational burden

一项针对具有高肿瘤突变负荷的晚期癌症的tremelimumab信号探索性II期研究

Thavaneswaran, Subotheni; Lin, Frank; Espinoza, David; Grady, John; Kok, Peey-Sei; Chinchen, Sarah; Pavlakis, Nick; Andelkovic, Vladimir; Charakidis, Michail; Craft, Paul; Brown, Michael; Desai, Jayesh; Lau, Peter; Kansara, Maya; Simes, John; Thomas, David

INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curse

INTEGATE 汇总的 2/3 期结果对疾病进展后的治疗方案转换和“赢家诅咒”具有稳健性

Soon, Yu Yang; Sjoquist, Katrin; Marschner, Ian C; Schou, I Manjula; Pavlakis, Nick; Goldstein, David; Shitara, Kohei; Stockler, Martin R; Simes, John; Martin, Andrew J

Peptide receptor chemoradionuclide therapy for neuroendocrine neoplasms: A systematic review

肽受体化疗放射性核素治疗神经内分泌肿瘤:系统评价

Chan, Dennis S; Kanagaratnam, Aran L; Pavlakis, Nick; Chan, David L

The gut microbiome as a potential predictive biomarker for breast cancer: emerging association and geographic differences

肠道微生物群作为乳腺癌潜在预测生物标志物:新兴关联和地域差异

Oh, Byeongsang; Lamoury, Gillian; Carroll, Susan; Morgia, Marita; Boyle, Frances; Pavlakis, Nick; Clarke, Stephen; Guminski, Alexander; Menzies, Alexander; Diakos, Connie; Moore, Katrina; Baron-Hay, Sally; Eade, Thomas; Molloy, Mark; Back, Michael

Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours

与其他实体瘤相比,胶质瘤患者能够维持疫苗诱导的免疫力。

Yuile, Alexander; Wei, Joe Q; McKelvey, Kelly J; Colvin, Emily K; Zakarya, Razia; Stoner, Shihani P; Jagadeesan, Advaitha; Yunus, Madiha; de Silva, Hasanthi C; Gilson, Josef; Leck, Lionel; Arzuman, Laila; Zhang, Otto; Oatley, Meredith; Pavlakis, Nick; Chan, David I; Itchins, Malinda; Kastelan, Marina; Lee, Adrian; Wheeler, Helen R; Menzies, Alexander; Diakos, Connie I; Guminski, Alexander; Back, Michael; Eade, Thomas; Jayamanne, Dasantha; Kneebone, Andrew; Hudson, Amanda L